Portal de investigación
CARACTERIZACIÓN DEL PATRÓN DE MICRORNAS EN LA MUERTE SÚBITA CARDIACA DE ORIGEN ISQUÉMICO. ANÁLISIS DE SU RELACIÓN CON LA DISLIPEMIA, LA GRASA EPICÁRDICA, LA ESTEATOSIS NO ALCOHÓLICA Y FACTORES DE COAGULACION Y FIBRINOLISIS.
Datos básicos
- Código:
- 2013_0454_CRC_ZORIO
- Dotación:
- 6.000,00 €
- Año inicial:
- 2014
- Año final:
- 2018
Objetivos del proyecto
FINALIZADO
Documentos
- No hay documentos
Participantes
-
Esther Zorio Grima
Investigador Principal
Grupos
-
Hemostasia, Trombosis, Arteriosclerosis y Biología vascular
Investigador Principal
Pilar Medina Badenes
-
Cardiopatías familiares, muerte súbita y mecanismos de enfermedad (CAFAMUSME)
Investigador Principal
Aitana Braza Boils
Financiadores
Resultados del Proyecto
Current knowledge of genetic risk factors for venous thrombosis
SILVIA NAVARRO ROSALES; (...); PILAR MEDINA BADENES
Capítulo de un Libro. 2014
"In Vitro" Evaluation of Energy-Based Sealing of Graft Side Branches in Bypass Surgery.
Miralles, Manuel; (...); Clara, Albert
Article. 10.1007/s00268-023-07107-0. 2023
349 - Clinical usefulness of eight novel monoclonal antibodies against prostate-specific antigen (PSA) to differentiate prostate cancer and benign prostate hyperplasia. Measurement of different PSA molecular forms with specific immunoassays
S. Navarro; (...); P. Medina-Badenes
Article. 10.1016/S1569-9056(17)30413-X. 2017
A MODIFICATION OF CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY TO EXPLORE NEW COFACTORS OF ACTIVATED PROTEIN C IN PLASMA
Martos, L.; (...); Navarro Rosales, S.
Meeting Abstract. 10.1016/S0049-3848(14)50233-2. 2014
A new mutation in the ryanodine receptor 2 gene (RYR2 C2277R) as a cause catecholaminergic polymorphic ventricular tachycardia.
Letter. 10.1016/j.rec.2014.07.022. 2015
A NOVEL TISSUE MICRORNA SIGNATURE FOR ARRHYTHMOGENIC CARDIOMYOPATHY
Zorio, E.; (...); Medina, P.
Article. 10.1016/S0049-3848(14)50269-1. 2014
A novel tissue microRNA signature for arrythmogenic cardiomyopathy.
Zorio, E; (...); Medina, P.
Article. 2014
A predictive model for prostate cancer incorporating PSA molecular forms and age.
Oto J; (...); Navarro S
Article. 10.1038/s41598-020-58836-4. 2020
A Series of 14 Polish Patients with Thrombotic Events and PC Deficiency-Novel c.401-1G>A PROC Gene Splice Site Mutation in a Patient with Aneurysms.
Weronska A; (...); Wypasek E
Article. 10.3390/genes13050733. 2022
A simplified assay for the quantification of circulating activated protein C
Martos L; (...); Medina P
Article. 10.1016/j.cca.2016.05.025. 2016
a2-Macroglobulin is a significant in vivo inhibitor of activated protein C and low levels of APC:a2M are associated with venous thromboembolism
Navarro S; (...); Medina P
Article. 2018
Activated protein C assays: a review.
Review. 10.1016/j.cca.2019.11.005. 2020
alpha(2)-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC: alpha M-2 Levels Are Associated with Venous Thromboembolism
Martos, L; (...); Medina, P
Article. 10.1055/s-0038-1629902. 2018
An International Multi-Center Cohort Study on ß-blockers for the Treatment of Symptomatic Children with Catecholaminergic Polymorphic Ventricular Tachycardia.
Peltenburg PJ; (...); Wilde AAM
Article. 10.1161/CIRCULATIONAHA.121.056018. 2022
Anthracycline mediated cardiotoxicity: Detection of miRNA based early biomarkers for the prediction of myocardial injury. Hecatos study
Coloma, C. Salvador; (...); Santaballa, A.
Meeting Abstract. 10.1093/annonc/mdw365.69. 2016
Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency
Navarro-Fernandez, J; (...); Vicente, V
Article. 10.1160/TH15-11-0871. 2016
Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice
Bernardo, Angel; (...); Medina, Pilar
Article. 10.3390/jcm11123345. 2022
Arrhythmogenic cardiomyopathy with left ventricular involvement versus ischemic heart disease: lessons learned from the family study and the reviewed autopsy of a young male.
Article. 10.1080/20961790.2019.1616247. 2019
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure
Akhtar, MM; (...); European Genetic Cardiomyopathies
Article. 10.1001/jamacardio.2021.1106. 2021
ASSOCIATIONS OF DISORDERS IN BONE MINERAL PARAMETERS WITH MORTALITY IN STAGE 4 AND 5 CKD: INSIGHTS FROM THE PECERA STUDY
Molina, Pablo; (...); Gorriz, JL
Meeting Abstract. 2020
ATP synthase subunit alpha and LV mass in ischaemic human hearts
Roselló-Lletí E; (...); Rivera M
Article. 10.1111/jcmm.12477. 2015
Biomarkers of venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis (HISPALIS study)
Candelera, RO; (...); Badenes, PM
Meeting Abstract. 2021
Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).
Otero, Remedios; (...); Medina, Pilar
Article. 10.3390/cancers14112771. 2022
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
Article. 10.3389/fimmu.2023.1171065. 2023
Cadaveric Adipose-Derived Stem Cells for Regenerative Medicine and Research.
Milian, Lara; (...); Zorio, Esther
Article. 10.3390/ijms242115696. 2023
Calprotectin as a new inflammatory marker of abdominal aortic aneurysm: A pilot study.
Plana E; (...); Miralles M
Article. 10.1177/1358863X241231494. 2024
Cardiac phenotype in glycogen storage disease type XV: a rare cardiomyopathy to bear in mind.
Mancheño N; (...); Zorio, Esther
Letter. 10.1016/j.recesp.2020.05.033. 2021
Cardiomyopathy associated with primary carnitine deficiency in adults: lack of complete response in patients with delayed treatment initiation
Cervera, Borja Guerrero; (...); Zorio, Esther
Letter. 10.1016/j.recesp.2023.08.011. 2024
Cardiomyopathy associated with primary carnitine deficiency in adults: lack of complete response in patients with delayed treatment initiation.
Guerrero Cervera B; (...); Zorio E
Case Reports. 10.1016/j.rec.2023.08.011. 2024
Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy.
Alania-Torres, Edgardo; (...); Valle-Munoz, Alfonso
Case Reports. 10.3389/fcvm.2021.759119. 2021
Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
Herranz, R; (...); Medina, P
Review. 10.3390/cancers13061448. 2021
Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y(12) Inhibition
Braza-Boils, A; (...); Mayr, M
Article. 10.3390/ijms21082897. 2020
Classification model based on strain measurements to identify patients with arrhythmogenic cardiomyopathy with left ventricular involvement.
Vives-Gilabert Y; (...); Castells F
Article. 10.1016/j.cmpb.2019.105296. 2020
Clinical and molecular characterization of a group of Spanish and German patients with Noonan syndrome
Lopez Gonzalez, Vanesa; (...); Guillen-Navarro, Encarna
Meeting Abstract. 2022
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.
Dominguez F; (...); Garcia-Pavia P
Article. 10.1016/j.hrthm.2020.01.035. 2020
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
Lopez-Sainz, A; (...); European Genetic Cardiomyopathies
Article. 10.1016/j.jacc.2020.05.029. 2020
Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry
Lopez-Sainz, A; (...); Garcia-Pavia, P
Article. 10.1016/j.rec.2018.04.035. 2019
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry.
Lotan D; (...); Arad M
Article. 10.1161/CIRCGEN.120.003117. 2020
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Casas, G; (...); Rodriguez-Palomares, JF
Article. 10.1016/j.jacc.2021.06.016. 2021
Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.
Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.
Meeting Abstract. 2024
COMBINED DEFICIENCY OF PROTEIN C, PROTEIN S AND ANTITHROMBIN IN PATIENTS WITH MESENTERIC OR PORTAL VENOUS THROMBOSIS WITH OR WITHOUT HEPATIC CIRRHOSIS
Martos, L.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50197-1. 2014
Comparison between hiPS-CM from RyR2-R420Q CPVT Patients and KI Mice Bearing the Same Mutation
Yin, LH; (...); Gomez, AM
Meeting Abstract. 2020
Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation
Ramon-Nunez, Luis A.; (...); Navarro, Silvia
Article. 10.1371/journal.pone.0187005. 2017
comprehensive CMR analysis improves risk stratification in left ventricular noncompaction
Casas, G.; (...); Rodriguez-Palomares, J. F.
Meeting Abstract. 2023
CONTRIBUTION OF NETOSIS IN ADVANCED STAGES OF HIGH-GRADE SEROUS OVARIAN CANCER: DIAGNOSTIC IMPLICATIONS
Alexandre, J. Mari; (...); Gilabert-Estelles, J.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.604. 2021
Crocetin Isolated from the Natural Food Colorant Saffron Reduces Intracellular Fat in 3T3-L1 Adipocytes
Jimenez-Ortega, E; (...); Llorens, S
Article. 10.3390/foods9111648. 2020
Changes in human skin composition due to intrinsic aging: a histologic and morphometric study.
Arnal-Forne, Marta; (...); Ruiz-Sauri, Amparo
Article. 10.1007/s00418-024-02305-w. 2024
Characterization of Ca2+ handling in induced-pluripotent cardiomyocytes from a CPVT family harbouring the RyR2(R420Q) mutation
Blasco, Almudena Val; (...); Gomez, Ana M.
Meeting Abstract. 2022
Characterization of hereditary transthyretin cardiac amyloidosis in Spain.
Alvarez Rubio, Jorge; (...); AC-TTRv-Spain Investigator Group
Article. 10.1016/j.rec.2021.07.020. 2022
Delving into the clinical impact of NETs in pediatric cancer.
Benavent N; (...); Medina P
Article. 10.1038/s41390-024-03437-4. 2024
Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease
Braza-Boils A; (...); Zorio E
Article. 10.1111/liv.13097. 2016
Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study)
Jimenez-Jaimez, J; (...); Tercedor, L
Article. 10.1016/j.amjcard.2015.06.030. 2015
Diagnostic power of echocardiographic speckle tracking of the tricuspid annular motion to assess right ventricular dysfunction
Alonso P; (...); Salvador A
Letter. 10.1016/j.ijcard.2013.12.157. 2014
Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing
Nunn LM; (...); Lambiase PD
Article. 10.1093/europace/euv285. 2016
Differences in the expression of microRNAs 16-5p and 451a after acute exercise in patients with thrombosis versus healthy subjects
Lopez, Veronica Sanchez; (...); Candelera, Remedios Otero
Meeting Abstract. 10.1183/13993003.congress-2024.PA535. 2024
Differential expression of miRNAs present in plasma and contained within circulating microparticles in precapillary pulmonary hypertension
Oto, Julia; (...); Albert Barbera, Joan
Meeting Abstract. 10.1183/13993003.congress-2019.PA5050. 2019
Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer
Oto, Julia; (...); Otero, Remedios
Meeting Abstract. 10.1183/13993003.congress-2021.PA593. 2021
Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
Dominguez, F; (...); Garcia-Pavia, P
Article. 10.1016/j.ijcard.2017.08.010. 2017
Disparate molecular mechanisms in cardiac ryanodine receptor channelopathies
Zhang, Yadan; (...); Zissimopoulos, Spyros
Article. 10.3389/fmolb.2024.1505698. 2024
Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation?
Rodríguez-Serrano M; (...); Salvador-Sanz A
Article. 10.1111/ctr.12282. 2014
Does the Calcineurin Inhibitor Have Influence on Cytomegalovirus Infection in Heart Transplantation?
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.067. 2014
Dysregulated neutrophil extracellular traps and haemostatic biomarkers as diagnostic tools and therapeutic targets in periprosthetic joint infection.
Oto, Julia; (...); Medina, Pilar
Article. 10.1302/0301-620X.106B9.BJJ-2024-0187.R1. 2024
Dyssynchrony Assessment in Arrhythmogenic Cardiomyopathy With Left Ventricular Involvement
Vives-Gilabert, Y; (...); Castells, F
Proceedings Paper. 10.22489/CinC.2018.073. 2018
Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia.
Laredo, Mikael; (...); Belhassen, Bernard
Article. 10.1093/europace/euac267. 2023
Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy.
Cabrera-Borrego, Eva; (...); Jimenez-Jaimez, Juan
Article. 10.1161/CIRCEP.124.013145. 2024
Endoplasmic Reticulum Stress Induces Different Molecular Structural Alterations in Human Dilated and Ischemic Cardiomyopathy
Ortega A; (...); Portolés M
Article. 10.1371/journal.pone.0107635. 2014
Extracellular Kir2.1(C122Y) Mutant Upsets Kir2.1-PIP(2) Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome.
Cruz FM; (...); Jalife J
Article. 10.1161/CIRCRESAHA.123.323895. 2024
Extrathoracic Aneurysms in Marfan Syndrome: A Systematic Review of the Literature.
Requejo-Garcia, Lucia; (...); Miralles-Hernandez, Manuel
Article. 10.1016/j.avsg.2022.08.005. 2022
Facts and Gaps in Exercise Influence on Arrhythmogenic Cardiomyopathy: New Insights From a Meta-Analysis Approach.
Martínez-Solé J; (...); Zorio E
Review. 10.3389/fcvm.2021.702560. 2021
Familial left ventricular noncompaction associated with a novel mutation in the alpha-cardiac actin gene.
Rodríguez-Serrano M; (...); Zorio E
Letter. 10.1016/j.rec.2014.05.015. 2014
Family Sudden Death Risk-Assessment Unit: Experience at the Valencian Community
Blasco, JG, Macian, II, Grima, EZ
Editorial Material. 2017
Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.
Hall CL; (...); McKenna WJ
Article. 10.1016/j.ijcard.2019.09.048. 2020
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
Bergeman, Auke T.; (...); van der Werf, Christian
Article. 10.1161/CIRCULATIONAHA.123.064786. 2023
Follow-up and prognosis of HCM.
Dominguez, Fernando; (...); Zorio, Esther
Article. 10.21542/gcsp.2018.33. 2018
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy
Ochoa, JP; (...); Monserrat, L
Article. 10.1016/j.jacc.2018.10.001. 2018
Functional Analysis of Two Haplotypes of the Human Endothelial Protein C Receptor Gene
Medina P; (...); España F
Article. 10.1161/ATVBAHA.113.302518. 2014
FUNCTIONAL ANALYSIS OF TWO HAPLOTYPES OF THE HUMAN ENDOTHELIAL PROTEIN C RECEPTOR GENE (PROCR)
Bonet, E.; (...); Navarro Rosales, S.
Meeting Abstract. 10.1016/S0049-3848(14)50053-9. 2014
Functional Effects of the RyR(2)(R420Q) Catecholaminergic Ventricular Polymorphic Tachycardia in Mouse Cardiomyocytes
Rizzetto, R; (...); Gomez, AM
Meeting Abstract. 10.1016/j.bpj.2016.11.551. 2017
Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy
Herrer I; (...); Rivera M
Article. 10.1186/s12920-015-0088-y. 2015
Genotype FBN1/Phenotype relationship in a cohort of patients with Marfan syndrome.
Hernándiz A; (...); Sepúlveda P
Article. 10.1111/cge.13879. 2020
Heart Mitochondrial Proteome Study Elucidates Changes in Cardiac Energy Metabolism and Antioxidant PRDX3 in Human Dilated Cardiomyopathy
Roselló-Lletí E; (...); Rivera M
Article. 10.1371/journal.pone.0112971. 2014
Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain.
de Frutos, Fernando; (...); Gonzalez-Costello, Jose
Article. 10.1016/j.rec.2024.12.012. 2025
Hypertrophic cardiomyopathy due to truncating variants in myosin binding protein C: a Spanish cohort
Melendo-Viu, Maria; (...); Palomino Doza, Julian A.
Article. 10.1136/openhrt-2024-002891. 2024
Identification and validation of plasma micrornas involved in venous and arterial thrombosis
Ramon, L. A.; (...); Navarro, S.
Meeting Abstract. 2015
IDENTIFICATION OF 58 MUTATIONS (26 NEW) IN 94 OF 109 BEING TESTED WITH PROTEIN DEFICIENCY C. SETH WORKING GROUP
Fernandez-Pardo, A.; (...); Navarro, S.
Meeting Abstract. 2019
Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency
Martos, L; (...); Spanish Soc Thrombosis Haemostasis
Article. 10.1055/s-0039-1692440. 2019
IDENTIFICATION OF 6 MUTATIONS IN THE PROTEIN C GENE (PROC) IN A PANEL OF 83 SPANISH FAMILIES WITH PROTEIN C DEFICIENCY
Martos, L.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50254-X. 2014
IDENTIFICATION OF A MICRORNA PROFILE RELATED TO HYPERTROPHIC CARDIOMYOPATHY
Plana, E.; (...); Medina, P.
Meeting Abstract. 10.1016/S0049-3848(14)50064-3. 2014
Identification of a microRNA profile related to hypertrophic cardiomyopathy. PUBLICACION: THROMBOSIS RESEARCH.
Plana, E; (...); Medina, P.
Article. 2014
IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN ARTERIAL THROMBOSIS
Navarro, S.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50273-3. 2014
IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN VENOUS THROMBOSIS
Navarro, S.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50271-X. 2014
IDENTIFICATION OF A PROFILE OF CLASSES OF CIRCULATING LIPIDS ASSOCIATED WITH THE VENOUS THROMBOEMBOLISM
Fernandez-Pardo, A.; (...); Navarro, S.
Meeting Abstract. 2019
Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs
Article. 10.3390/ijms22157913. 2021
Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
Article. 10.3390/biomedicines8110447. 2020
Identification of Novel microRNA Profiles Dysregulated in Plasma and Tissue of Abdominal Aortic Aneurysm Patients
Plana E; (...); Miralles M
Article. 10.3390/ijms21134600. 2020
Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registry.
Larrañaga-Moreira JM; (...); Barriales-Villa R
Article. 10.1016/j.medcli.2023.06.025. 2023
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
Gimeno, Juan R.; (...); Lakdawala, Neal K.
Article. 10.1002/ehf2.13964. 2022
Impaired Binding to Junctophilin-2 and Nanostructural Alteration in CPVT Mutation
Yin L; (...); Gómez AM
Article. 10.1161/CIRCRESAHA.121.319094. 2021
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
Protonotarios, Alexandros; (...); Elliott, Perry M.
Article. 10.1093/eurheartj/ehac235. 2022
Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor
López-Vilella R; (...); Montero-Argudo A
Article. 10.1016/j.transproceed.2014.11.025. 2015
Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor (vol 47, pg 127, 2015)
Lopez-Vilella, R.; (...); Montero-Argudo, A.
Article. 10.1016/j.transproceed.2015.09.023. 2015
Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C
Martos L; (...); Medina P
Article. 10.3390/ijms21165651. 2020
Increased circulating dna, calprotectin and mieloperoxidase, as neutrophil extracellular trap markers, are risk factors for deep vein thrombosis
Martos, L.; (...); Medina, P.
Meeting Abstract. 2015
INCREASED LEVELS OF FREE CIRCULATING DNA AND DNASE 1 ACTIVITY IN PLASMA IS ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLISM
Oto, J.; (...); Medina, P.
Meeting Abstract. 2019
Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients' biofluids: Potential role in disease diagnosis and management.
Tomás-Pérez S; (...); Gilabert-Estellés J
Article. 10.3389/fimmu.2023.1111344. 2023
Indirect effects of cytomegalovirus infection and the utility of utility of valganciclovir
Martinez-Dolz, L.; (...); Almenar-Bonet, L.
Article. 2014
Initial Experience with a New Image Integration Module Designed for Reducing Radiation Exposure During Electrophysiological Ablation Procedures
Cano Ó; (...); Martínez-Dolz L
Article. 10.1111/jce.12659. 2015
Intra-plaque calcium and its relation with the progression of carotid atheromatous disease.
Miralles, Manuel; (...); Plana, Emma
Article. 10.23736/S0392-9590.22.04872-6. 2022
Intravenous sildenafil in right ventricular dysfunction with pulmonary hypertension following a heart transplant.
Bonet LA; (...); Sanz AS
Article. 10.5301/HEART.2014.12492. 2014
LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer
Oto, Julia; (...); Medina, Pilar
Article. 10.1007/s00345-022-04136-7. 2022
Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine.
Casas, Guillem; (...); Rodriguez-Palomares, Jose F
Article. 10.1016/j.rec.2025.01.011. 2025
Left ventricular myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis
Vives-Gilabert, Y; (...); Zorio, E
Article. 10.1016/j.ijcard.2018.09.024. 2019
Long term outcomes in left ventricular non-compaction
Casas, G; (...); Rodriguez-Palomares, JF
Meeting Abstract. 2020
Long-term prognosis of women with Brugada syndrome and electrophysiological study.
Rodríguez-Mañero M; (...); Arbelo E
Article. 10.1016/j.hrthm.2020.12.020. 2021
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.
Deguchi, H; (...); Griffin, JH
Article. 10.1002/rth2.12018. 2017
Mechanism of Sinoatrial Node Dysfunction in a RyR(2)R420Q Mouse Model Ofcatecholaminergic Polymorphic Ventricular Tachycardia
Wang, YY; (...); Gomez, AM
Meeting Abstract. 10.1016/j.bpj.2016.11.2924. 2017
Metabolomic study for the identification of symptomatic carotid plaque biomarkers
Botello-Marabotto, Marina; (...); Miralles, Manuel
Article. 10.1016/j.talanta.2024.127211. 2025
MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors
Braza-Boïls A; (...); Estellés A
Article. 10.1093/humrep/deu019. 2014
MICRORNA EXPRESSION PROFILE IN EPICARDIAL FAT IN SUDDEN CARDIAC DEATH FROM CORONARY ARTERY DISEASE
Braza-Boils, A.; (...); Zorio, E.
Article. 2014
Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: their relationship with sterility
Mari-Alexandre, J; (...); Gilabert-Estelles, J
Article. 10.1016/j.fertnstert.2017.11.036. 2018
microRNAs and angiogenesis in endometriosis
Mari-Alexandre, J; (...); Gilabert-Estelles, J
Article. 10.1016/S0049-3848(15)50439-8. 2015
microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors
Article. 10.3390/cancers12061536. 2020
MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
Article. 10.3390/ijms21030840. 2020
MicroRNAs as predictors of chronic thromboembolic pulmonary hypertension
Otero Candelera, Remedios; (...); Sanchez Lopez, Veronica
Meeting Abstract. 10.1183/13993003.congress-2023.OA4831. 2023
microRNAs modulate human tissue factor pathway inhibitor-A (TFPIA) expression in response to androgens in endothelial cells
Rodriguez, A. B. A.; (...); Gonzalez-Conejero, R.
Meeting Abstract. 2015
miRNAs Regulation and Its Role as Biomarkers in Endometriosis
Marí-Alexandre J; (...); Sandoval J
Review. 10.3390/ijms17010093. 2016
Modification of a thrombin generation test to identify new cofactors of the protein C pathway in plasma
Martos, L.; (...); Navarro, S.
Meeting Abstract. 2015
Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy.
Mirelis JG; (...); Ibáñez B
Article. 10.1016/j.rec.2017.01.026. 2017
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1
Mazzanti, A; (...); Priori, SG
Article. 10.1016/j.jacc.2020.02.033. 2020
Natural History of MYH7-related Dilated Cardiomyopathy.
de Frutos, Fernando; (...); Garcia-Pavia, Pablo
Article. 10.1016/j.jacc.2022.07.023. 2022
Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker
Lopez-Sainz, A; (...); Garcia-Pavia, P
Letter. 10.1186/s13023-019-1140-3. 2019
Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer.
Castano, Maria; (...); Gilabert-Estelles, Juan
Article. 10.3390/ijms24065995. 2023
New ECG biomarkers and sex-stratified models for the detection of Arrhythmogenic Cardiomyopathy with left ventricular involvement
Jimenez-Serrano, Santiago; (...); Castells, Francisco
Article. 10.1016/j.bspc.2024.107224. 2025
New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression.
Castano, Maria; (...); Gilabert-Estelles, Juan
Editorial Material. 10.3390/ijms24087604. 2023
Non Coding RNAs as Regulators of Wnt/ß-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy
Piquer-Gil, Marina; (...); Zorio, Esther
Review. 10.3390/biomedicines10102619. 2022
Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.
Domingo, D; (...); Zorio, E
Article. 10.1016/j.rec.2014.04.023. 2015
Novel contributions of neutrophils in the pathogenesis of abdominal aortic aneurysm, the role of neutrophil extracellular traps: A systematic review
Plana, E; (...); Miralles, M
Review. 10.1016/j.thromres.2020.07.039. 2020
Novel insights on Andersen-Tawil syndrome type 1
Mazzanti, A; (...); ATS1 Int Res Grp
Meeting Abstract. 2020
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives.
Cabrera-Romero E; (...); Garcia-Pavia P
Article. 10.1016/j.jacc.2024.02.036. 2024
Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis
Braza-Boils, A; (...); Martinez, C
Article. 10.1093/humrep/dev204. 2015
Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy.
Bermudez-Jimenez FJ; (...); Jimenez-Jaimez J
Article. 10.1016/j.jacep.2024.02.031. 2024
Phenotypic Patterns of Cardiomyopathy Caused by Mutations in the Desmin Gene. A Clinical and Genetic Study in Two Inherited Heart Disease Units.
Ripoll-Vera, T; (...); Cremer, D
Letter. 10.1016/j.rec.2015.07.007. 2015
Plan of Action for Inherited Cardiovascular Diseases: Synthesis of Recommendations and Action Algorithms.
Barriales-Villa, R; (...); Garcia-Pavia, P
Article. 10.1016/j.rec.2015.11.029. 2016
PLASMATIC DNA STIMULATES THE GENERATION OF IN VITRO THROMBIN EVEN IN THE ABSENCE OF EXTRINSIC TISSUE FACTOR AND CAN BE REVERSED WITH DNA'S
Fernandez-Pardo, A.; (...); Medina, P.
Meeting Abstract. 2019
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
Sabater Molina, Maria; (...); Gimeno Blanes, Juan R.
Article. 10.1371/journal.pone.0263140. 2022
Postmortem genetic testing should be recommended in sudden cardiac death cases due to thoracic aortic dissection
Gago-Diaz, M; (...); Brion, M
Article. 10.1007/s00414-017-1583-9. 2017
POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
Calvete O; (...); Benitez J
Article. 10.1161/JAHA.119.012875. 2019
Predictors of adverse cardiovascular events in patients with truncating variants in the filamin c (flnc) gene
Akhtar, M.; (...); Elliott, P. M.
Meeting Abstract. 2019
Predictors of systemic embolisms in a large cohort of left ventricular noncompaction patients
Casas, G.; (...); Rodriguez-Palomares, J. F.
Meeting Abstract. 2019
Pregnancy in women with dilated cardiomyopathy genetic variants.
Restrepo-Córdoba MA; (...); García-Pavía P
Article. 10.1016/j.rec.2024.04.002. 2024
Prevalence of fragmented QRS complex and factors related with its occurrence
Martinez-Dolz, L.; (...); Almenar-Bonet, L.
Article. 2014
Prognosis of left ventricular noncompaction with preserved ejection fraction
Casas, G.; (...); Rodriguez-Palomares, J. F.
Meeting Abstract. 2021
Psychosocial and adaptation factors in relatives of patients who died of sudden cardiac death
Rubio, AS; (...); Martin, CPB
Article. 2017
Quantitative immunoassay for the measurement of activated protein C complexes with Alfa-2-macroglobulin (APC:alpha M-2)
Espana, F.; (...); Medina, P.
Meeting Abstract. 2015
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients.
Cano J; (...); Romero L
Article. 10.3389/fphar.2020.580481. 2020
Rare Genetic Variants in Young Adults Requiring Pacemaker Implantation.
Ochoa, Juan Pablo; (...); Garcia-Pavia, Pablo
Article. 10.1016/j.jacep.2024.05.008. 2024
Reduced Levels of miR-145-3p Drive Cell Cycle Progression in Advanced High-Grade Serous Ovarian Cancer
Gonzalez-Canto, Eva; (...); Mari-Alexandre, Josep
Article. 10.3390/cells13221904. 2024
Renin-angiotensin system polymorphisms as potential modifier in COVID-19 outcome
Sabater Molina, Maria; (...); Gimeno Blanes, Juan Ramon
Meeting Abstract. 2022
RNA Sequencing Analysis and Atrial Natriuretic Peptide Production in Patients with Dilated and Ischemic Cardiomyopathy
Tarazón E; (...); Portolés M
Article. 10.1371/journal.pone.0090157. 2014
RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.
Hall CL; (...); Syrris P
Article. 10.1016/j.ijcard.2019.12.002. 2020
Role of microRNAs associated with non-alcoholic fatty liver disease in sudden cardiac death from coronary artery disease
Braza-Boils, A.; (...); Zorio, E.
Meeting Abstract. 10.1093/cvr/cvu082.6. 2014
Role of miRNA-mRNA Interactome in Pathophysiology of Arrhythmogenic Cardiomyopathy.
Bonet, Fernando; (...); Toro, Rocio
Article. 10.3390/biomedicines12081807. 2024
Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets.
Oto, Julia; (...); Gotte, Martin
Article. 10.3390/cancers15123125. 2023
ROLE OF THE MIRNAS OF PLATELETS IN THE EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH CORONARY DISEASE
Zorio, E.; (...); Braza-Boils, A.
Meeting Abstract. 2019
RyR(2)(R420Q) catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism
Wang, YY; (...); Gomez, AM
Article. 10.1172/jci.insight.91872. 2017
Screening of microRNAs as possible biomarkers in abdominal aortic aneurysm
Plana, E; (...); Miralles, M
Article. 10.1016/j.angio.2017.09.001. 2018
Sensitivity and negative predictive value of treadmill exercise stress testing for the diagnosis of catecholaminergic polymorphic ventricular tachycardia. Response.
Domingo, D; (...); Zorio, E
Letter. 10.1016/j.rec.2015.02.011. 2015
Sex differences in aortic prognosis in Marfan patients, a retrospective longitudinal study from the REPAG registry
Tura, G. Teixido; (...); Cabrera, F.
Meeting Abstract. 10.1093/eurheartj/ehae666.2264. 2024
Simulation of the effects of flecainide and ranolazine under LQTS type 3 produced by the heterozygous SCN5A V411M mutant
Garcia, JC; (...); Perez, LR
Meeting Abstract. 10.1016/j.vascn.2020.106720. 2020
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
Study and prevention of sudden infant death: An experience in the Valencian community
Blasco, AM; (...); Grima, EZ
Article. 2017
Study of New Criteria Based on Eigenvalue Decomposition to Assist Arrhythmogenic Cardiomyopathy Diagnosis
Jimenez-Serrano, S; (...); Castells, F
Proceedings Paper. 2016
Systematic Implantation of Pacemaker/ICDs under Active Oral Anticoagulation Irrespective of Patient's Individual Preoperative Thromboembolic Risk
Cano Ó; (...); Martínez-Dolz L
Article. 10.1111/pace.12613. 2015
The Adult Macaque Spinal Cord Central Canal Zone Contains Proliferative Cells and Closely Resembles the Human
Alfaro-Cervello C; (...); Garcia-Verdugo JM
Article. 10.1002/cne.23501. 2014
The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
Rouhi L; (...); Marian AJ
Article. 10.1093/cvr/cvab197. 2021
The genetic background of left ventricular hypertrabeculation/noncompaction remains vague. Response.
Rodríguez-Serrano M; (...); Zorio E
Letter. 10.1016/j.rec.2014.10.001. 2015
The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients
Tell-Marti, G; (...); Puig, S
Article. 10.1007/s12035-016-0305-5. 2017
The Potential of Extracellular Microvesicle-microRNAs in Precapillary Pulmonary Hypertension.
Tura-Ceide, Olga; (...); Barbera, Joan Albert
Article. 10.1165/rcmb.2024-0282LE. 2025
The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy.
Belhassen, Bernard; (...); Milman, Anat
Article. 10.1093/europace/euab190. 2021
The RyR2(R420Q) Mutation Triggers Catecholaminergic Polymorphic Ventricular Tachycardia in Mouse Cardiomyocytes via SR Calcium Loading
Fernandez-Tenorio, M; (...); Niggli, E
Meeting Abstract. 2018
The RyR2R420Q+/- Mutation Triggers Arrhythmogenic Ca2+Events in Mouse Cardiomyocyte
Lopez, R; (...); Nigglil, E
Meeting Abstract. 2019
The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results
Osca J; (...); Salvador A
Article. 10.1093/europace/euv211. 2016
Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death Victims.
Mari-Alexandre J; (...); Zorio E
Article. 10.1016/j.rec.2017.12.007. 2019
Thrombospondins in human aortic aneurysms.
Plana, Emma; (...); Miralles, Manuel
Article. 10.1002/iub.2610. 2022
Titin Missense Variants as a Cause of Familial Dilated Cardiomyopathy.
Dominguez, Fernando; (...); Garcia-Pavia, Pablo
Letter. 10.1161/CIRCULATIONAHA.122.062833. 2023
Translating cancer epigenomics into the clinic: focus on lung cancer
Mari-Alexandre, J; (...); Sandoval, J
Review. 10.1016/j.trsl.2017.05.008. 2017
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Ortiz-Genga, MF; (...); Monserrat, L
Article. 10.1016/j.jacc.2016.09.927. 2016
Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer
Article. 10.1007/s11934-020-0962-9. 2020
Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study
Article. 10.1016/j.jprot.2020.103723. 2020
Use of a "CNI holidays" strategy in acute renal dysfunction late after heart transplant. Report of two cases.
Article. 2014
VALIDATION OF A MODEL WITH COAGULATION-RELATED MARKERS FOR THE DIAGNOSIS OF PROSTHETIC JOINT INFECTION
Oto, J.; (...); Medina, P.
Meeting Abstract. 2019
Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study.
Rodríguez-Mañero M; (...); Arbelo E
Article. 10.1016/j.rec.2021.07.007. 2021
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Oto, Julia; (...); Medina, Pilar
Article. 10.1016/j.jprot.2024.105357. 2025
Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome.
Muñoz-Esparza C; (...); Gimeno Blanes JR
Article. 10.1016/j.rec.2017.01.006. 2017
Value of the Electrocardiogram as a Predictor of Right Ventricular Dysfunction in Patients With Chronic Right Ventricular Volume Overload.
Alonso P; (...); Salvador A
Article. 10.1016/j.rec.2014.04.019. 2015
Efecto Del Acenocumarol Sobre El Sistema Anticoagulante De La Proteína C
Autor/es: Ana Rosa Cid Haro
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Estudio Del Papel De Los Micrornas En El Desarrollo De Cáncer De Próstata En Pacientes Con Hiperplasia Benigna
Autor/es: Ana Julia Oto Martínez
Tesis de Máster
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Estudio Funcional De Polimorfismos De La Vía De Activación De La Proteína C
Autor/es: Elena Bonet Estruch
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Identificación De Nuevas Moléculas Con Actividad Anticoagulante Y/O Citoprotectora En La Vía De La Proteína C: Explorando Su Utilidad Clínica.
Autor/es: Álvaro Fernández Pardo
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales; Luís Andrés Ramón Núñez
Influencia De Los Nuevos Anticoagulantes Orales Sobre El Sistema De Activación De La Proteína C
Autor/es: Santiago Bonanad Boix
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Marcadores Circulantes Del Riesgo De Trombosis: Micrornas, Nets Y Generación De Trombina. Su Utilidad Para El Tratamiento Individualizado Del Paciente Con Trombosis
Autor/es: Laura Martos Marín
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Campos de estudio
Cita
CARACTERIZACIÓN DEL PATRÓN DE MICRORNAS EN LA MUERTE SÚBITA CARDIACA DE ORIGEN ISQUÉMICO. ANÁLISIS DE SU RELACIÓN CON LA DISLIPEMIA, LA GRASA EPICÁRDICA, LA ESTEATOSIS NO ALCOHÓLICA Y FACTORES DE COAGULACION Y FIBRINOLISIS. (2013_0454_CRC_ZORIO). ASTRAZENECA FARMACÉUTICA SPAIN, S.A.; FUNDACION ESPAÑOLA DE TROMBOSIS Y HEMOSTASIA. 2014-2018. IP:ESTHER ZORIO GRIMA.